Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb Max Pain By Strike
BMY trades at $48.47, 3.1% above the near-term max pain of $47 expiring Aug 22, 2025 (6 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($45-$52.5), indicating stable market expectations. Key magnetic zone at 47 where 8 expirations converge.
Bristol-Myers Squibb Max Pain By Expiry
Max pain for BMY shows stable levels around 48.09, reflecting balanced market expectations. The 16% spread signals divergent expectations across timeframes. Levels distributed around 48.47. Strong magnetic level at 47 (8 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 22, 2025 | 47 | -1.47 (-3.02%) |
| Aug 29, 2025 | 46.5 | -1.97 (-4.05%) |
| Sep 5, 2025 | 47 | -1.47 (-3.02%) |
| Sep 12, 2025 | 45 | -3.47 (-7.15%) |
| Sep 19, 2025 | 47 | -1.47 (-3.02%) |
| Sep 26, 2025 | 47 | -1.47 (-3.02%) |
| Oct 17, 2025 | 45 | -3.47 (-7.15%) |
| Nov 21, 2025 | 47 | -1.47 (-3.02%) |
| Dec 19, 2025 | 50 | 1.53 (3.17%) |
| Jan 16, 2026 | 49 | 0.53 (1.10%) |
| Mar 20, 2026 | 48 | -0.47 (-0.96%) |
| Jun 18, 2026 | 50 | 1.53 (3.17%) |
| Sep 18, 2026 | 47 | -1.47 (-3.02%) |
| Dec 18, 2026 | 47 | -1.47 (-3.02%) |
| Jan 15, 2027 | 52.5 | 4.03 (8.33%) |
| Jun 17, 2027 | 50 | 1.53 (3.17%) |
| Dec 17, 2027 | 52.5 | 4.03 (8.33%) |